10 April 2017

Pediatric Praziquantel Consortium awarded US$4.7 million GHIT grant

On 30 Mar 2017, the GHIT Fund announced that it will continue to support the Pediatric Praziquantel Consortium. 

After being awarded grants in 2014 (US$ 1,86m) and 2015 (US$ 4,9m) for its phase I and II program, respectively, the latest grant of US$4.7m will allow the Consortium to perform its phase III program and submit the registration file. The Consortium is excited to continue its partnership with the GHIT Fund, which has been an important success factor in moving ahead with the pediatric praziquantel program.

Further details on the grant and the pediatric praziquantel development program are highlighted in the GHIT Fund press release.